Pages that link to "Q39171961"
The following pages link to Non-kinase targets of protein kinase inhibitors (Q39171961):
Displaying 28 items.
- Applications of CRISPR genome editing technology in drug target identification and validation (Q38708498) (← links)
- Combined CRISPRi/a-Based Chemical Genetic Screens Reveal that Rigosertib Is a Microtubule-Destabilizing Agent (Q42377052) (← links)
- Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery (Q47323180) (← links)
- A Comprehensive Structural Overview of p38α Mitogen-Activated Protein Kinase in Complex with ATP-Site and Non-ATP-Site Binders (Q47324721) (← links)
- Conflicting evidence for the role of JNK as a target in breast cancer cell proliferation: Comparisons between pharmacological inhibition and selective shRNA knockdown approaches (Q50124623) (← links)
- The Role of Kinase Modulators in Cellular Senescence for Use in Cancer Treatment. (Q51800912) (← links)
- Marine-derived protein kinase inhibitors for neuroinflammatory diseases. (Q52565796) (← links)
- Kinase inhibitors: the road ahead. (Q52653219) (← links)
- mus-52 disruption and metabolic regulation in Neurospora crassa: Transcriptional responses to extracellular phosphate availability. (Q52691433) (← links)
- How to Achieve Better Results Using PASS-Based Virtual Screening: Case Study for Kinase Inhibitors. (Q54110122) (← links)
- Determination of protein kinase A activity and inhibition by using hydroxyapatite nanoparticles as a fluorescent probe. (Q54118803) (← links)
- CRISPR/Cas-based customization of pooled CRISPR libraries. (Q55424921) (← links)
- Drug repurposing: progress, challenges and recommendations (Q57471980) (← links)
- Commentary: Usage of Mitogen-Activated Protein Kinase Small Molecule Inhibitors: More Than Just Inhibition! (Q58735041) (← links)
- Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models (Q59129787) (← links)
- Staurosporine, an inhibitor of hormonally up-regulated neu-associated kinase (Q59809185) (← links)
- Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells (Q61798864) (← links)
- CRISPR/Cas9 - An evolving biological tool kit for cancer biology and oncology (Q64081762) (← links)
- A multitargeted probe-based strategy to identify signaling vulnerabilities in cancers. (Q64911527) (← links)
- Kinase-Inactivated EGFR Is Required for the Survival of Wild-Type EGFR-Expressing Cancer Cells Treated with Tyrosine Kinase Inhibitors. (Q64988694) (← links)
- Pharmacological plasticity-How do you hit a moving target? (Q78177016) (← links)
- An isothermal shift assay for proteome scale drug-target identification (Q89723136) (← links)
- Rethink of EGFR in Cancer With Its Kinase Independent Function on Board (Q90053595) (← links)
- Chemical proteomics reveals target selectivity of clinical Jak inhibitors in human primary cells (Q90441063) (← links)
- SGC-GAK-1: A Chemical Probe for Cyclin G Associated Kinase (GAK) (Q91616902) (← links)
- Pathogenic stromal cells as therapeutic targets in joint inflammation (Q93017920) (← links)
- A New Quantitative Cell-Based Assay Reveals Unexpected Microtubule Stabilizing Activity of Certain Kinase Inhibitors, Clinically Approved or in the Process of Approval (Q95270450) (← links)
- Flavopiridol causes cell cycle inhibition and demonstrates anti-cancer activity in anaplastic thyroid cancer models (Q99707502) (← links)